Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000055

Chief Financial Officer sold 3,195 shares at $14.97 ($47,832)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
WENTWORTH KORY JAMES Chief Financial Officer 2024-09-09 Sale 10b5-1 −3,195 $14.97 $47,832 76,486 D
Open-market sales · 3,195 sh · avg $14.97 · $47,832
Loading xslF345X05/wk-form4_1726000485.xml…